SCHEMBL20054515

SCHEMBL20054515

CC1C[C@@H]2CC(F)(F)C[C@@H]2C1

nearest known ligand 0.32

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
APLNR P35414 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20054804 0.83
SCHEMBL16512585 0.83
SCHEMBL18781236 0.81
SCHEMBL17490369 0.75 APLNR (0.35) APLNR
SCHEMBL497813 0.74
SCHEMBL21427331 0.73 APLNR (0.42) APLNR
SCHEMBL23394247 0.73 APLNR (0.32) APLNR
SCHEMBL25474668 0.72
SCHEMBL23940378 0.71 APLNR (0.32) APLNR
SCHEMBL24538267 0.71 APLNR (0.38) APLNR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2802326-B1 HEPATITIS C VIRUS INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2018-04-18 EP disclosed